|
TMEM70 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.635200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.728200E-02 |
| Normal-vs-Stage2 |
4.466400E-01 |
| Normal-vs-Stage3 |
5.850600E-01 |
| Normal-vs-Stage4 |
5.452400E-01 |
| Stage1-vs-Stage2 |
6.596800E-01 |
| Stage1-vs-Stage3 |
2.402800E-01 |
| Stage1-vs-Stage4 |
5.902400E-01 |
| Stage2-vs-Stage3 |
3.868200E-01 |
| Stage2-vs-Stage4 |
9.185600E-01 |
| Stage3-vs-Stage4 |
4.284600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.771000E-01 |
| Normal-vs-AfricanAmerican |
9.356200E-01 |
| Normal-vs-Asian |
6.389400E-01 |
| Caucasian-vs-AfricanAmerican |
6.665000E-01 |
| Caucasian-vs-Asian |
5.482400E-01 |
| AfricanAmerican-vs-Asian |
7.523000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.210600E-01 |
| Normal-vs-Female |
8.389200E-01 |
| Male-vs-Female |
2.623400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.484200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.750400E-02 |
| Normal-vs-Age(61-80Yrs) |
8.912400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.427400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.210200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.050600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.454600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.618170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.216800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.919000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.383000E-01 |
| Normal-vs-Grade 2 |
6.810200E-01 |
| Normal-vs-Grade 3 |
1.477840E-01 |
| Normal-vs-Grade 4 |
7.293200E-01 |
| Grade 1-vs-Grade 2 |
9.826400E-01 |
| Grade 1-vs-Grade 3 |
8.568800E-01 |
| Grade 1-vs-Grade 4 |
8.682200E-01 |
| Grade 2-vs-Grade 3 |
5.564800E-01 |
| Grade 2-vs-Grade 4 |
5.752400E-01 |
| Grade 3-vs-Grade 4 |
2.496600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.04239999965117E-07 |
| Normal-vs-ccB subtype |
1.270760E-01 |
| ccA subtype-vs-ccB subtype |
8.831500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.843800E-01 |
| Normal-vs-N1 |
9.391600E-01 |
| N0-vs-N1 |
8.918400E-01 |
|
|
